|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/485 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61P 25/04 | (2006.01) |
| (11) | Number of the document | 1414459 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02761250.6 |
| Date of filing the European patent application | 2002-08-05 | |
| (97) | Date of publication of the European application | 2004-05-06 |
| (45) | Date of publication and mention of the grant of the patent | 2009-12-02 |
| (46) | Date of publication of the claims translation | 2010-03-25 |
| (86) | Number | PCT/US2002/024889 |
| Date | 2002-08-05 |
| (87) | Number | WO 2003/013538 |
| Date | 2003-02-20 |
| (30) | Number | Date | Country code |
| 309791 P | 2001-08-06 | US | |
| 208817 | 2002-08-01 | US |
| (72) |
WRIGHT, Curtis, IV, US
CARPANZO, Anthony, E., US
|
| (73) |
EURO-CELTIQUE S.A.,
1, rue Jean Piret, 2350 Luxembourg,
LU
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Peroralinė vaisto forma, apimanti terapinį agentą ir priešingo poveikio agentą |
| ORAL DOSAGE FORM COMPRISING A THERAPEUTIC AGENT AND AN ADVERSE-EFFECT AGENT |
| Payment date | Validity (years) | Amount | |
| 2018-07-19 | 17 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-08-05 |